Stockwinners Market Radar for January 25, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:55 EDT Kao Chemicals appoints Univar as distributor in Spain and Portugal - Europe, Univar B.V., a subsidiary of Univar, said that Kao Chemicals has appointed Univar as its distributor in Spain and Portugal. The appointment marks an expanded agreement with Kao Chemicals where Univar increases its offering for the home and industrial cleaning, as well as beauty and personal care markets.

17:12 EDT Boeing awarded $2.46B Navy contract modification for P-8A lot 10 aircraft - Boeing has been awarded a $2.46B modification to a previously awarded firm-fixed-price, cost-plus-fixed-fee contract. This modification provides for the production and delivery of 19 P-8A lot 10 aircraft to include 10 for the Navy, four for the government of the U.K. and five for the government of Norway. In addition, this modification includes engineering change proposal 4 SilverBlock for the government of the U.K. and Lot 10 segregable efforts consisting of unknown obsolescence, Class I change assessments and obsolescence monitoring. Work will be performed in Seattle, Washington; Baltimore, Maryland; Greenlawn, New York; Cambridge, U.K. and various locations within and outside the continental U.S., and is expected to be completed in March 2022. FY19 aircraft procurement and foreign military sales, or FMS, funds in the amount of $2.46B will be obligated at time of award, none of which will expire at the end of the current fiscal year. This modification combines purchases for the Navy, the government of Norway and the government of the U.K., under the FMS program. The Naval Air Systems Command is the contracting activity.

16:25 EDT iFresh trading halted, news pending

16:20 EDT Independent Bank shareholders approve Blue Hills Bancorp acquisition - Shareholders of Independent Bank (INDB), parent of Rockland Trust, approved the merger of Independent and Blue Hills Bancorp (BHBK) pursuant to the agreement and plan of merger, dated as of September 20, 2018. Subject to the terms of the merger agreement, Blue Hills Bancorp will merge with and into Independent, with Independent surviving the merger, and Blue Hills Bank will merge with and into Rockland Trust, with Rockland Trust surviving the merger. At the effective time of the merger, Blue Hills Bancorp's stockholders will receive in exchange for each share of Blue Hills Bancorp common stock, $5.25 in cash and 0.2308 of a share of Independent common stock in accordance with the terms and conditions of the merger agreement. The merger remains subject to regulatory approval and other customary closing conditions. The merger is expected to close in the first half of 2019.

16:17 EDT KAR Auction launches Data as a Service program to optimize dealer profitability - KAR Auction Services announced the launch of a pilot program for its Data as a Service suite of capabilities during the Auto Intel Council news conference at NADA Show 2019. Powered by DRIVIN, acquired by KAR in 2017, these new DaaS capabilities leverage data and technology from across the KAR platform and use proprietary algorithms to deliver clear, easy, actionable intelligence to dealers. By integrating data science, predictive analytics and machine learning into the dealer remarketing process, dealers can save time and may increase sales margins and cash flow. Dealers participating in the pilot get a holistic snapshot of what is in demand, the vehicles that could provide the best return on investment and how to best dispose of less desirable vehicles - all specifically relevant to their individual rooftop. KAR provides the pilot program dealers with lot-specific reports containing inventory segmentation analyses, purchase recommendations and remarketing advice - giving dealers targets for the best vehicle mix, propensity to sell and optimal disposal channel. As the pilot continues, KAR is fine-tuning the reporting and algorithms based on feedback from pilot program dealers, sales information and market reports.

16:12 EDT Franklin Resources reports 8.2% passive stake in Dermira - In a regulatory filing, Franklin Resources disclosed a 8.2% stake in Dermira, which represents about 3.5M shares. The filing does not allow for activism.

16:06 EDT Dynagas LNG lowers quarterly dividend to 6.25c from 25c per share - The dividend is payable on February 14, 2019 to all common unitholders of record on February 7, 2019.

16:02 EDT CM7Star extends period to complete deal with Renren's Kaixin - CM Seven Star Acquisition Corporation (CMSS), a blank check company formed for the purpose of entering into a business combination with one or more businesses, announced that it received a notice from its sponsor, Shareholder Value Fund, to extend the time required for the company to complete its proposed business combination with Kaixin Auto Group, a premium used car dealership network in China owned by, Renren Inc. (RENN) for an additional three-months, ending April 30, 2019. Promptly after delivering the notice, the Sponsor, or its designees, and Kaixin deposited an aggregate amount of approximately $2.1M, representing 10c per public share, into the company's trust account pursuant to the terms of the investment management trust agreement entered into by the company at the time of the company's initial public offering and pursuant to the terms of the definitive share exchange agreement previously entered into by the company and Kaixin. On November 6, 2018, CM7Star announced it had entered into a definitive share exchange agreement with Kaixin and its owner, Renren, to acquire 100% of Kaixin's equity holdings for an initial consideration of approximately 28.3M CM7Star shares, subject to certain indemnification arrangements, in a transaction valued at approximately $454M. For further information about such transaction, please refer to CM7Star's SEC filings.

16:00 EDT Franklin Resources reports 6.9% passive stake in Coty - In a regulatory filing, Franklin Resources disclosed a 6.9% stake in Coty, which represents about 51.8M shares. The filing does not allow for activism.

15:34 EDT Siebert Financial to acquire 15% stake in StockCross Financial Services - Siebert Financial announced that its wholly-owned subsidiary, Muriel Siebert & Co acquired a 15% ownership of StockCross Financial Services, Inc., one of the largest privately-owned brokerage firms in the nation. In Q4 of 2017, Siebert acquired approximately $4 billion in customer assets of StockCross' retail securities business, and added StockCross' nationwide sales force consisting of approximately 40 employees. In connection with this transaction, MSCO and StockCross entered into a clearing agreement in which StockCross agreed to act as one of MSCO's clearing brokers.

15:27 EDT Kornitzer Capital reports 5.3% passive stake in Landmark Bancorp, Inc. - In a regulatory filing, Kornitzer Capital disclosed a 5.3% stake in Landmark Bancorp, which represents about 220,000 shares. The filing does not allow for activism.

15:18 EDT Air Products, Saudi Aramco to jointly-build fuel cell vehicle fueling station - Saudi Aramco and Air Products (APD) announced the signing of an agreement to jointly-build the first hydrogen fuel cell vehicle fueling station in Saudi Arabia. The collaboration between the two companies will combine Air Products' technological know-how and experience in the field of hydrogen with Saudi Aramco's industrial experience, facilities and R&D capabilities. Saudi Aramco and Air Products will establish a pilot fleet of fuel cell vehicles for which high-purity compressed hydrogen will be dispensed at the new fueling station. Air Products' proprietary SmartFuel hydrogen fueling technology will be incorporated into the new station to supply the vehicles with compressed hydrogen. The collected data during this pilot phase of the project will provide valuable information for the assessment of future applications of this emerging transport technology in the local environment. The hydrogen refueling station, the first in the Kingdom, is expected to be operational in the second quarter of 2019. Toyota Motor (TM) will supply Toyota Mirai Fuel Cell Vehicles for testing in this pilot project.

13:27 EDT Wells Fargo CEO says waiving fees for customers impacted by shutdown - CEO Tim Sloan tells CNBC's Jim Cramer that the bank is waiving fees for customers impacted by the government shutdown. Sloan, who added that the lender is going to extend payments for customers, said the bank is talking to 14,400 customers affected by the shutdown.

13:19 EDT Naspers to invest additional $1.16B in Avito through OLX Group - Naspers's Classifieds business, OLX Group, announced an investment of $1.16B, at an implied enterprise value of $3.85B, to acquire a further 29.1% stake in Avito, an online general classifieds and property platform in Russia. OLX Group's stake increases from 70.4% to 99.6% on a fully diluted basis. The remaining shares are held by existing management. The transaction closed on January 25, 2019 and was funded by Naspers' existing cash resources.

13:03 EDT Baker Hughes reports U.S. rig count up 9 to 1,059 rigs - Baker Hughes reports that the U.S. rig count is up 9 rigs from last week to 1,059 rigs, with oil rigs up 10 to 862 and gas rigs down 1 to 197. The U.S. Rig Count is up 112 rigs from last year's count of 947, with oil rigs up 103 and gas rigs up 9. The U.S. Offshore Rig Count is up 1 rig to 20 and up 3 rigs year-over-year. The Canada Rig Count is up 23 rigs from last week to 232, with oil rigs up 18 to 146 and gas rigs up 5 to 86. The Canada Rig Count is down 106 rigs from last year's count of 338, with oil rigs down 74 and gas rigs down 32.

12:53 EDT IQVIA retained to manage OncoQuest Phase 3 clinical cancer study - OncoQuest a privately held, cancer immunotherapy company, has retained the services of IQVIA to manage OncoQuest's planned Phase 3 clinical study in frontline ovarian cancer with the company's lead product candidate, oregovomab, an anti-CA-125 antibody. OncoQuest will collaborate with IQVIA to provide oversight of the day-to-day study execution activities.

12:37 EDT Enova, CFPB agree to $3.2M civil money penalty over payment processing issues - Enova International announced that it has reached an agreement with the Consumer Financial Protection Bureau addressing payment processing issues that Enova identified and self-disclosed to the CFPB in 2014. The issues arose from technical systems errors, all of which have since been resolved. Although the CFPB has determined that no customer restitution is required, Enova has agreed to a $3.2M civil money penalty. The consent order between Enova and the CFPB covers two payment processing issues that, combined, impacted less than 0.2% of total payments processed by Enova during the period in which the errors occurred. The technical processes that caused these errors were corrected, and customers were contacted for remediation of damages they may have incurred.

12:03 EDT Coherus Biosciences files patent infringement suit against Amgen over biosimilar - Coherus BioSciences (CHRS) announced it has filed suit against Amgen (AMGN) in the United States District Court alleging that Amgen's Humira biosimilar, Amgevita, infringes Coherus' U.S. patents 10,155,039; 10,159,732; and 10,159,733. Each of the asserted Coherus patents is directed to stable formulations of adalimumab. Coherus' Humira biosimilar candidate, CHS-1420, is among a number of significant biosimilar candidates in Coherus' pipeline of high-value treatments for patients in need, including biosimilar candidates directed to Enbrel, Lucentis, and Eylea. Coherus is currently preparing its biologics license application for CHS-1420 for submission to the U.S. Food and Drug Administration, with anticipated filing in late 2019. Upon the expected U.S. market launch of CHS-1420 in late 2023, the company believes it will be well-positioned to effectively leverage the commercial infrastructure it has already deployed for its recent U.S. launch of UDENYCA. The company continues to evaluate options and potential strategies for ex-U.S. commercialization of CHS-1420.

12:00 EDT PG&E falls -11.5% - PG&E is down -11.5%, or -$1.60 to $12.35.

12:00 EDT Huya rises 10.7% - Huya is up 10.7%, or $2.14 to $22.22.

12:00 EDT Bristow Group rises 23.2% - Bristow Group is up 23.2%, or 80c to $4.24.

11:47 EDT PUBG Corp. hosts beta test for free 'PUBG Lite' standalone game in Thailand - PUBG Corp., the company behind popular battle royale game "PlayerUnknown's Battlegrounds," announced yesterday that the "PUBG Lite" beta test is now available in Thailand only for now. The beta will help the company determine if this is a viable for other regions, the company said. PUBG Corp's goal for "PUBG Lite" is to "deliver the 'PlayerUnknown's Battlegrounds' experience to players in areas where the core game's required specifications are more difficult to achieve due to the hardware available. To this end, the 'PUBG Lite' team has focused on balancing lower hardware requirements, without compromising on our quality standards. The end result is a build that is playable even on computers and laptops utilizing integrated graphics." "PUBG Lite" is a free, standalone product, the company said. The core "PUBG" game is available on PC, Xbox One (MSFT), mobile, and PlayStation 4 (SNE). The Fly notes that the game is a battle royale game similar to Epic Games' "Fortnite." Investors in Epic Games include Tencent (TCEHY), KKR (KKR), and Disney (DIS).

11:05 EDT FAA says 'slight increase in sick leave' experienced at two airports - The FAA has issued a staffing update statement via Twitter, stating: "We have experienced a slight increase in sick leave at two facilities. We are mitigating the impact by augmenting staffing, rerouting traffic, and increasing spacing between aircraft when needed." Publicly traded airlines include American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV) and United Continental (UAL). Reference Link

10:36 EDT Visa 'considering its options' regarding Earthport after MasterCard offer - Visa, Inc. and Visa International Service Association (V) note the announcement of an offer by Mastercard UK Holdco Limited (MA) for the entire issued and to be issued ordinary share capital of Earthport plc on January 25, 2019 "Visa is considering its options and a further announcement will be made in due course," the company said in regulatory statement to the London Stock Exchange.

10:00 EDT Dean Foods falls -7.2% - Dean Foods is down -7.2%, or -36c to $4.61.

10:00 EDT ResMed falls -16.8% - ResMed is down -16.8%, or -$19.70 to $97.59.

10:00 EDT JinkoSolar rises 8.0% - JinkoSolar is up 8.0%, or $1.08 to $14.64.

09:58 EDT FAA reports Traffic Management Program in effect for LaGuardia due to staffing - FAA's Air Traffic Control System Command Center issued the following update: "Due to OTHER / ZDC + ZJX STAFFING and OTHER / STAFFING, there is a Traffic Management Program in effect for traffic arriving La Guardia Airport, New York, NY (LGA). This is causing some arriving flights to be delayed an average of 41 minutes." Publicly traded airlines include American Airlines (AAL), Delta Air Lines (DAL), JetBlue (JBLU), Southwest (LUV) and United Continental (UAL). Reference Link

09:47 EDT New Oriental Education rises 5.2% - New Oriental Education is up 5.2%, or $3.83 to $77.81.

09:47 EDT Canopy Growth rises 6.2% - Canopy Growth is up 6.2%, or $2.73 to $46.94.

09:41 EDT Starbucks CEO says competition in China expanding addressable market - Kevin Johnson is speaking on CNBC.

09:32 EDT AbbVie says 'not contemplating' a large M&A deal

09:16 EDT Frequency Electronics awarded $4.5M government contract - Frequency Electronics announced that it has been selected for an approximately $4.5M contract to supply precision timing and microwave frequency generation systems for a secure U.S. Government space application. These systems will augment the capabilities of an existing constellation of satellites for which Frequency previously provided similar equipment. Work on the contract will be completed within 18 months of contract award.

09:11 EDT Ligand announces partner Seelos Therapeutics becomes public company - Ligand Pharmaceuticals (LGND) partner Seelos Therapeutics (SEEL) announced that it has closed a reverse merger with Apricus Biosciences (APRI). The combined company changed its name to Seelos Therapeutics, which is publicly traded on the Nasdaq Capital Market under the trading symbol "SEEL," and will focus on the development and commercialization of central nervous system therapeutics with known mechanisms of action in areas with high unmet medical need. Seelos is led by Chairman and CEO Raj Mehra, Ph.D. In conjunction with the reverse merger transaction, Seelos issued common stock and warrants for an aggregate purchase price of $18M. In September 2016, Ligand licensed rights to four programs to Seelos, which include: SLS-006: first-in-class, small molecule, partial dopamine agonist for Parkinson's disease. SLS-006 has successfully completed Phase 2 studies. Seelos intends to meet with the U.S. Food and Drug Administration and the European Medicines Authority to discuss plans for pivotal registration studies to commence in 2019. SLS-006 has shown efficacy in early-stage Parkinson's disease patients as a monotherapy and as a potential adjunctive therapy in late-stage Parkinson's disease patients upon co-administration with a low dosage of L-Dopa. SLS-008: once-daily, oral CRTh2 that focuses on an undisclosed pediatric orphan indication. Seelos intends to file an Investigational New Drug application with the FDA for this pediatric orphan indication. SLS-010: oral histamine 3 receptor inverse agonist that has shown activity in narcolepsy and related disorders. SLS-012: Captisol-enabled injectable acetaminophen therapy for post-operative pain management.

09:09 EDT Immersion's haptic technology licensed to Not Impossible Labs - Immersion has signed a multi-year license agreement with Not Impossible Labs, an R&D lab and content studio. The relationship enables Not Impossible to employ Immersion's patented haptic technology for its Vibrotextile wearables. Music: Not Impossible is the first public project from Not Impossible Labs that employs Immersion's haptic technology. The wearable technology enables hearing and deaf audiences to feel the nuances of music via the skin. Using the skin as a canvas, M:NI translates music into vibrations. In the future, Not Impossible will debut VibroHealth, which also employs Immersion technology, to improve the quality of life for those affected by motor-related issues.

09:06 EDT Polar Power sees "continued positive revenue growth" in 2019 - Polar Power stated: "We believe that currently we have a relatively small market share of the U.S. telecom backup power generator market with significant opportunities among the top-tier carriers as well as the fragmented "last mile" service providers. During 2018, we narrowed the price difference between our products and top brand AC generator products, while delivering what we believe is a more reliable and fuel-efficient product solution. During 2018, we received product certification from most of the major Tier-1 telecommunication providers in the U.S. market and initial orders from key international customers. We believe these accomplishments, combined with expanded international sales infrastructure, positions us for continued positive revenue growth in 2019 (...) Our strategic investments in plant automation and equipment has provided us with significantly higher production capacity for 2019. We believe this increase in plant capacity will enable us to not only increase market share with our existing Tier-1 customers, but also provide us with the ability to target and serve new customers and geographies".

09:06 EDT Fly Intel: Pre-market Movers - UP AFTER EARNINGS: Starbucks (SBUX), up 3%... Lear (LEA), up 1%... Western Digital (WDC), up 11%. ALSO HIGHER: General Electric (GE), up 1% after announcing modified terms to its previously announced merger of Wabtec (WAB) and GE Transportation... Albermarle (ALB), up 3% after announcing the company has reached an agreement with the Chilean Economic Development Agency, or Corfo, on the process for establishing and validating the preferential price and terms to be offered to specialized manufacturers and that Corfo will not file the previously disclosed arbitration claim... CalAmp (CAMP), up 3% after JPMorgan analyst Paul Coster upgraded the stock to Overweight with an unchanged price target of $17. The analyst cites valuation for the upgrade and believes the company's supply chain issues will be resolved in 2019. DOWN AFTER EARNINGS: Intel (INTC), down 6%... AbbVie (ABBV), down 3%... Colgate-Pamolive (CL), down 2%... Intuitive Surgical (ISRG), down 3%... ResMed (RMD), down 16%. ALSO LOWER: PG&E (PCG), down 8% after saying it still faces "extensive litigation" even after Cal Fire's announcement that the company's facilities did not cause the Tubbs wildfire.

09:05 EDT Disney reports extension of exchange offers for 21st Century Fox notes - The Walt Disney Company (DIS) announces the extension of the expiration date of the offers to exchange any and all outstanding notes issued by 21st Century Fox America (FOXA) for up to $18,128,740,000 aggregate principal amount of new notes to be issued by TWDC Holdco 613 Corp. and cash and the related consent solicitations being made by New Disney on behalf of 21CFA to adopt certain proposed amendments to the indentures governing the 21CFA Notes. New Disney hereby extends such expiration date from 5:00 p.m., New York City time, on February 1, 2019, to 5:00 p.m., New York City time, on February 5, 2019.

09:04 EDT Zimmer Biomet receives FDA 510(k) clearance for ROSA Knee System - Zimmer Biomet announced U.S. FDA 510(k) clearance of the ROSA Knee System for robotically-assisted total knee replacement surgeries. ROSA Knee features 3D pre-operative planning tools and real-time, intraoperative data on soft-tissue and bone anatomy designed to improve bone cut accuracy and range of motion gap analysis to potentially improve flexion and restoration of natural joint movement.

09:00 EDT D.R. Horton CEO says 2019 will be 'a good year' - Management said demand is improving "week after week." The company is pursuing select acquisitions. Management feels less pressured to offer incentives for buyers.

08:49 EDT D.R. Horton sees Q2 revenue $3.9B-$4.1B, consensus $4.09B

08:47 EDT D.R. Horton expects Forestar Group to remain profitable - D.R. Horton (DHI) management expects Forestar (FOR) to remain profitable and achieve gross margins of approximately 10% by FY20.

08:41 EDT Wabtec, General Electric modify terms of GE Transportation merger agreement - Wabtec (WAB) and General Electric (GE) announced they have modified the terms of their merger agreement and will publicly file S4 and S1 registration statements, respectively, with the SEC. The planned merger of Wabtec and GE Transportation, a business unit of GE, is expected to close by the end of February, subject to satisfaction or waiver of customary closing conditions. At closing, Wabtec plans to report its Q4 and full year results, and to provide FY19 guidance for the combined company. Under the terms of the modified arrangements, which have been approved by Wabtec's board and by the finance and capital allocation committee of the GE board, GE will complete the spin off of a portion of GE Transportation to GE shareholders and immediately thereafter merge GE Transportation into a wholly owned subsidiary of Wabtec. Upon closing, Wabtec shareholders will own approximately 50.8% of Wabtec on a fully diluted basis, compared to approximately 49.9% under the previous terms. GE shareholders will directly own approximately 24.3% of Wabtec on a fully diluted basis and GE will own common stock and non-voting convertible preferred stock which together represent approximately a 24.9% economic interest in Wabtec on a fully diluted basis, up from the 9.9% stake that GE would have owned under the originally announced transaction terms. GE will also receive approximately $2.9B in cash at closing, as announced in May. In aggregate, Wabtec will issue 3.3M fewer shares than originally contemplated. Under this modified structure, the spin-off will be considered a taxable dividend for U.S. federal income tax purposes. GE will sell down its interest in Wabtec subject to certain staggered lock-up provisions and size constraints designed to facilitate an orderly disposition of its shares. The GE interest is valued at $3.4B based on Wabtec's current market stock price of $71.03. No sales can be made for 30 days post-closing and GE must complete all sales before the third anniversary of the merger closing, subject to limited exceptions for market conditions.

08:40 EDT Marathon Partners urges e.l.f. Beauty to review operating strategy - Marathon Partners, which beneficially own approximately 8.6% of the common stock of e.l.f. Beauty, Inc., announced that it has delivered a letter to the Board of Directors of e.l.f. urging the Board to undertake a comprehensive review of the company's operating strategy, corporate governance practices and executive compensation. In its letter to the Board, Marathon Partners outlines a number of recommendations, including cost rationalization, corporate governance improvements and changes to executive compensation that it believes will increase shareholder value and improve potential outcomes for public shareholders. Marathon Partners recommends that the Board take the following actions to enhance e.l.f.'s corporate governance practices: Separate the role of Chairman and CEO. Assign a non-TPG designated director to the role of Lead Independent Director. Engage independent counsel to fully reassess the Second Amended and Restated Stockholders Agreement dated March 3, 2017. Reference Link

08:34 EDT Cheniere Energy Partners raises quarterly cash distributions to 59c per unit - Cheniere Energy Partners declared a cash distribution per common and subordinated unit of 59c, $2.36 annualized, to unitholders of record as of February 6, 2019, and the related distribution to its general partner. All of these distributions are payable on February 14, 2019.

08:34 EDT Core-Mark appoints Rocky Dewbre to its board, increases board to 10 members - Core-Mark announced that it has appointed Rocky Dewbre to its board of directors. The size of Core-Mark's board was increased from nine to ten members in connection with this new appointment. Dewbre is the CEO of Empire Petroleum Partners in Dallas, Texas.

08:30 EDT Ameris Bancorp sees FY19 normalized ROTCE 17%-19% - Says "confident" in 2019 financial expectations. Sees $20M of operating efficiencies, including in data processing, branch realignment. Comments from Q4 earnings presentation slides.

08:20 EDT NuCana withdraws offering of ADSs - NuCana announced that it has withdrawn the proposed underwritten offering of american depositary shares, or ADSs. The company believes it is not in the best interest of its shareholders to raise equity capital in the current market environment. The company has a cash position of approximately GBP77M as of December 31, 2018 to fund its key programs.

08:11 EDT Coherus Biosciences announces CHS-1420 settlement agreements with AbbVie - Coherus BioSciences (CHRS) announced it has executed settlement agreements with AbbVie (ABBV) that grant Coherus global, non-exclusive license rights under AbbVie's intellectual property to commercialize CHS-1420, Coherus' proposed adalimumab biosimilar. The global settlements resolve all pending disputes between the parties related to Coherus' adalimumab biosimilar. Under the U.S. settlement, Coherus' license period in the U.S. commences on December 15, 2023. Coherus will pay royalties to AbbVie. Financial terms are not disclosed.

08:01 EDT Zayo Group selected by cybersecurity firm for E-LAN solution - An internet analytics and cybersecurity firm has selected Zayo Group for an E-LAN solution, which provides high-capacity networks for the customer's security solution along with an internal network. The diverse solution leverages Zayo's network across the U.S. and Western Europe. Zayo's strong network backbone and exceptional responsiveness were key factors in earning this business.

07:49 EDT AbbVie reports Q4 revenues from hematologic oncology portfolio $1.13B - Global net revenues from the hematologic oncology portfolio were $1.13B, an increase of 50.2% on a reported basis; global IMBRUVICA net revenues were $1.006B, an increase of 42%; global VENCLEXTA net revenues were $124M. Fourth-quarter global HCV net revenues were $862M.

07:46 EDT AbbVie reports Q4 adjusted operating margin 41.7%

07:30 EDT Allergan raises quarterly dividend to 74c per share - The Board declared a cash dividend for the first quarter of 2019 to be paid on March 15 to shareholders of record at the close of business on February 15.

07:12 EDT Helius Medical receives request from FDA for AI letter for PoNS - Helius Medical announced that it has received a request for an additional information, or AI, letter from the FDA related to the company's request for De Novo classification and 510 clearance of the Portable Neuromodulation Stimulator, or PoNS device. During the substantive review phase of a request for De Novo classification and 510 clearance, FDA may request additional information in order to obtain information necessary for the agency to continue or complete its review and, in such instances, places its review on hold until the requested information is submitted.

07:06 EDT Vectrus subsidiary wins $151M Navy task order - Vectrus Systems Corporation, a wholly-owned subsidiary of Vectrus, was awarded a $151M cost-plus-fixed-fee task order to continue providing end-to-end engineering support for Command, Control, Communications, Computer, Intelligence systems under the Navy's Fleet Systems Engineering Team program. The task order was solicited and awarded under the Navy's SeaPort-e contract and extends through January 2024, including all option periods.

07:05 EDT Iberiabank sees FY19 average earning assets $28.6B-$28.9B - Sees FY19: Net interest margin 3.6%-3.7%; Consolidated loan growth 5% ~ 7%; Tax rate 23%-24%; Share repurchase activity $135M-$150M; Credit quality stable.

07:01 EDT MasterCard and Earthport announce terms of recommended cash offer - Mastercard and Earthport PLC published a Rule 2.7 announcement under the City Code on Takeovers and Mergers regarding an agreement on the terms of a recommended all cash offer by Mastercard UK Holdco, an indirectly, wholly-owned subsidiary of Mastercard, for the entire issued and to be issued ordinary share capital of Earthport. Earthport shareholders will be entitled to receive 33 pence in cash for each Earthport share. The acquisition values the entire issued and to be issued ordinary share capital of Earthport at approximately GBP233M, approximately $305M on a fully diluted basis.

06:49 EDT Boston Scientific announces four-year data for Rezum Water Vapor Therapy - Boston Scientific announced that data from a randomized clinical trial demonstrate that Rezum Water Vapor Therapy, a minimally invasive treatment for benign prostatic hyperplasia, or BPH, provides durable results and preserves sexual function four years after treatment. The study, published online ahead of print by Urology, found that patients continued to experience significant and sustained improvement in their symptoms and quality of life over this period. The Rezum System treats the symptoms of BPH by using water vapor to kill prostate adenoma cells, leading to the cell remnants being absorbed by the body. The procedure can be performed in a physician's office without general anesthesia in a single visit and does not require implants to be placed in the body. The Rezum System is included in The American Urological Association's BPH treatment guidelines and now has four-year follow-up data showing it can reduce the size of the prostate in all areas of enlarged prostate zones. Over the four years, the trial showed a surgical retreatment rate of 4.4% and no new adverse events noted between years three and four. The clinical results also highlighted continued preservation of sexual function, including no de novo erectile dysfunction reported at four years.

06:37 EDT Rand Capital receiving $25M strategic investment by East Asset Management - Rand Capital has entered into a stock purchase agreement to sell approximately 8.3 million shares of Rand Capital's common stock to East Asset Management for $25M in cash and $11.5M in portfolio assets. The purchase price of $3.00 per share represents a 33% premium over the January 24 closing price of $2.26 per share. The sale and issuance of common stock is subject to shareholder and regulatory approval. EAM will hold approximately 57% of shares outstanding following the share purchase. A new entity, Rand Capital Management, will be established as an external management company and will be retained by Rand Capital to be its investment advisor. RCM's operations will remain in Buffalo, New York, with Allen Grum as CEO and Daniel Penberthy as CFO. They will continue as well as members of RCM's investment committee. The retention of RCM to externalize the management structure is also subject to shareholder approval. The proposed transactions are expected to close during Q3. Following the close, Rand will continue to trade on Nasdaq under "RAND" and will operate as an externally-managed business development corporation. Rand intends to elect to become a regulated investment company for federal tax purposes. To qualify, Rand's Board of Directors intends to declare a special dividend of an estimated $22M, or $1.50 per share. The dividend amount is subject to final determination of the estimate after closing. The dividend is expected to be comprised of 20% cash and 80% stock. Each shareholder will have the opportunity to elect to receive the dividend in cash or additional shares of Rand stock.

06:32 EDT D.R. Horton Chairman says 'we are well-positioned for fiscal 2019' - Donald Horton, Chairman of the Board, said, "The D.R. Horton team delivered solid results for the first fiscal quarter of 2019. Net income for the quarter increased 52% to $287.2 million on a 6% increase in consolidated revenues to $3.5 billion. Our pre-tax profit margin for the first quarter was 10.7%, and our home sales revenues increased 7%. These results reflect the strength of our experienced operational teams, industry-leading market share, broad geographic footprint and affordable product offerings across multiple brands. Sales prices for both new and existing homes have increased across most of our markets over the past several years, which coupled with rising interest rates has impacted affordability and resulted in some moderation of demand for homes, particularly at higher price points. However, we continue to see good demand and a limited supply of homes at affordable prices across our markets, and economic fundamentals and financing availability remain solid. We are pleased with our product offerings and positioning for the upcoming spring selling season, and we will adjust to future changes in market conditions as necessary. Our continued strategic focus is to consolidate market share while growing our revenues and profits, generating strong cash flows and returns and maintaining a flexible financial position. With 33,700 homes in inventory at the end of December and 309,400 lots owned and controlled, we are well-positioned for fiscal 2019 and future years."

06:11 EDT Apple shipped 2.5M fewer smartphones in China in 2018 vs. 2017 - According to the latest research from Strategy Analytics, China smartphone shipments tumbled 11 percent annually to reach 108 million units in the fourth quarter of 2018. Huawei was the star performer and clear market leader, while Apple and Xiaomi lost ground. Apple shipped an estimated 34.2 million iPhones in China in 2018, down from 36.7 million in 2017, according to the data.

05:16 EDT ClearOne prevails against Shure in trial before U.S. PTAB - ClearOne announced that the Patent Trial and Appeal Board, or PTAB, of the United States Patent and Trademark Office, or USPTO, yesterday issued a final written decision confirming the patentability of all claims of U.S. Patent No. 9,264,553. The '553 Patent covers aspects of ClearOne's revolutionary innovations in beamforming microphone arrays, or BMAs. The case at the PTAB was brought by Shure, Inc., which ClearOne has accused of infringing multiple ClearOne patents covering fundamental BMA technology in federal court. ClearOne's BMA technology is protected by at least a dozen patents and pending patent applications. In the U.S. District Court for the Northern District of Illinois, ClearOne has asserted that Shure infringes U.S. Patent No. 9,635,186, which is a direct descendant of the '553 Patent, as well as U.S. Patent No. 9,813,806, directed at a BMA integrated into a ceiling tile.The case number at the PTAB is IPR2017-01785.